GBA Group and Nicoya Lifesciences join hands
We are pleased to announce our Channel Partner Agreement with Nicoya, representing their complete range of product line in the Middle East for sales, aftermarket consumables and technical and application support.
Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. The world’s first digital high-throughput benchtop SPR instrument, is capable of accelerating Research at Academia, drug discovery research using a fraction of sample volume traditionally required for biomolecular interaction analyses, helping biotechnology and pharmaceutical companies go-to-market faster with increased efficiency and success early in their product pipelines.